Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion - PubMed (original) (raw)
Comparative Study
Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion
D I Phillips et al. Diabet Med. 1994 Apr.
Abstract
The extent to which the oral glucose tolerance test can be used to estimate insulin secretion and insulin resistance has been evaluated by comparing glucose and insulin concentrations during an oral glucose tolerance test with specific measurements of insulin secretion and insulin resistance in 85 normoglycaemic subjects and 23 subjects with impaired glucose tolerance (IGT). Insulin secretion was measured by the first phase insulin response to intravenous glucose and insulin resistance by the insulin tolerance test which measures the decline of plasma glucose after the injection of a bolus of insulin. The best measure of insulin secretion was the ratio of the 30 min increment in insulin concentration to the 30 min increment in glucose concentration following oral glucose loading. This correlated with the first phase insulin release following intravenous glucose (r = 0.61, p < 0.001) but not insulin resistance (r = -0.05, p > 0.05). Insulin resistance could be estimated by the fasting insulin, proinsulin, or split proinsulin concentrations. However, fasting split proinsulin appeared to discriminate best between insulin resistance (r = -0.53, p < 0.001) and insulin secretion (r = 0.07, p > 0.05). Relative insulin resistance estimated by homeostasis model assessment (HOMA) also correlated well with insulin resistance (r = -0.57, p < 0.001) but not insulin secretion (r = 0.01, p > 0.05). We conclude that the oral glucose tolerance test can be used to derive estimates of the relative roles of insulin secretion and insulin resistance in population studies of glucose tolerance.
Comment in
- The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion.
Wareham NJ, Phillips DI, Byrne CD, Hales CN. Wareham NJ, et al. Diabet Med. 1995 Oct;12(10):931. doi: 10.1111/j.1464-5491.1995.tb00399.x. Diabet Med. 1995. PMID: 8846687 No abstract available.
Similar articles
- Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects.
Matsumoto K, Miyake S, Yano M, Ueki Y, Yamaguchi Y, Akazawa S, Tominaga Y. Matsumoto K, et al. Diabetes Care. 1997 Oct;20(10):1562-8. doi: 10.2337/diacare.20.10.1562. Diabetes Care. 1997. PMID: 9314636 - Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study.
Hanefeld M, Koehler C, Fuecker K, Henkel E, Schaper F, Temelkova-Kurktschiev T; Impaired Glucose Tolerance for Atherosclerosis and Diabetes study. Hanefeld M, et al. Diabetes Care. 2003 Mar;26(3):868-74. doi: 10.2337/diacare.26.3.868. Diabetes Care. 2003. PMID: 12610051 - [Insulin release kinetics and insulin sensitivity in impaired glucose tolerance].
Kikuchi M. Kikuchi M. Nihon Rinsho. 1996 Oct;54(10):2658-66. Nihon Rinsho. 1996. PMID: 8914424 Review. Japanese. - [Practical diagnosis in insulin resistance and beta-cell dysfunction and resulting therapeutic consequences].
Pfützner A, Forst T. Pfützner A, et al. MMW Fortschr Med. 2004 May 13;146(20):32-3, 35. MMW Fortschr Med. 2004. PMID: 15344730 Review. German. No abstract available.
Cited by
- Effect of Resected Gastric Volume on Ghrelin and GLP-1 Plasma Levels: a Prospective Study.
Sista F, Abruzzese V, Clementi M, Carandina S, Amicucci G. Sista F, et al. J Gastrointest Surg. 2016 Dec;20(12):1931-1941. doi: 10.1007/s11605-016-3292-y. Epub 2016 Oct 13. J Gastrointest Surg. 2016. PMID: 27738878 - Insulin resistance and impaired pancreatic β-cell function in adult offspring of women with diabetes in pregnancy.
Kelstrup L, Damm P, Mathiesen ER, Hansen T, Vaag AA, Pedersen O, Clausen TD. Kelstrup L, et al. J Clin Endocrinol Metab. 2013 Sep;98(9):3793-801. doi: 10.1210/jc.2013-1536. Epub 2013 Jun 24. J Clin Endocrinol Metab. 2013. PMID: 23796568 Free PMC article. - Synthesis, Antioxidant, and Antidiabetic Activities of Ketone Derivatives of Succinimide.
Waheed B, Mukarram Shah SM, Hussain F, Khan MI, Zeb A, Jan MS. Waheed B, et al. Evid Based Complement Alternat Med. 2022 Mar 28;2022:1445604. doi: 10.1155/2022/1445604. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35388310 Free PMC article. - The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes.
Kahn SE. Kahn SE. Diabetologia. 2003 Jan;46(1):3-19. doi: 10.1007/s00125-002-1009-0. Epub 2003 Jan 11. Diabetologia. 2003. PMID: 12637977 Review. - The effect of early insulin therapy on pancreatic β-cell function and long-term glycemic control in newly diagnosed type 2 diabetic patients.
Chon S, Oh S, Kim SW, Kim JW, Kim YS, Woo JT. Chon S, et al. Korean J Intern Med. 2010 Sep;25(3):273-81. doi: 10.3904/kjim.2010.25.3.273. Epub 2010 Aug 31. Korean J Intern Med. 2010. PMID: 20830224 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical